104 related articles for article (PubMed ID: 30449313)
1. Environmental risk assessment of metformin and its transformation product guanylurea. I. Environmental fate.
Straub JO; Caldwell DJ; Davidson T; D'Aco V; Kappler K; Robinson PF; Simon-Hettich B; Tell J
Chemosphere; 2019 Feb; 216():844-854. PubMed ID: 30449313
[TBL] [Abstract][Full Text] [Related]
2. Environmental risk assessment of metformin and its transformation product guanylurea: II. Occurrence in surface waters of Europe and the United States and derivation of predicted no-effect concentrations.
Caldwell DJ; D'Aco V; Davidson T; Kappler K; Murray-Smith RJ; Owen SF; Robinson PF; Simon-Hettich B; Straub JO; Tell J
Chemosphere; 2019 Feb; 216():855-865. PubMed ID: 30385066
[TBL] [Abstract][Full Text] [Related]
3. Incomplete aerobic degradation of the antidiabetic drug Metformin and identification of the bacterial dead-end transformation product Guanylurea.
Trautwein C; Kümmerer K
Chemosphere; 2011 Oct; 85(5):765-73. PubMed ID: 21752423
[TBL] [Abstract][Full Text] [Related]
4. Occurrence of the antidiabetic drug Metformin and its ultimate transformation product Guanylurea in several compartments of the aquatic cycle.
Trautwein C; Berset JD; Wolschke H; Kümmerer K
Environ Int; 2014 Sep; 70():203-12. PubMed ID: 24954924
[TBL] [Abstract][Full Text] [Related]
5. Environmental Concentrations of the Type 2 Diabetes Medication Metformin and Its Transformation Product Guanylurea in Surface Water and Sediment in Ontario and Quebec, Canada.
Littlejohn C; Renaud JB; Sabourin L; Lapen DR; Pappas JJ; Tuteja B; Hughes D; Ussery E; Yeung KK; Sumarah MW
Environ Toxicol Chem; 2023 Aug; 42(8):1709-1720. PubMed ID: 37283207
[TBL] [Abstract][Full Text] [Related]
6. Occurrence, toxic effects and removal of metformin in the aquatic environments in the world: Recent trends and perspectives.
Elizalde-Velázquez GA; Gómez-Oliván LM
Sci Total Environ; 2020 Feb; 702():134924. PubMed ID: 31726346
[TBL] [Abstract][Full Text] [Related]
7. Comprehensive study of the antidiabetic drug metformin and its transformation product guanylurea in Greek wastewaters.
Kosma CI; Lambropoulou DA; Albanis TA
Water Res; 2015 Mar; 70():436-48. PubMed ID: 25562582
[TBL] [Abstract][Full Text] [Related]
8. Filling in the Gaps in Metformin Biodegradation: a New Enzyme and a Metabolic Pathway for Guanylurea.
Tassoulas LJ; Robinson A; Martinez-Vaz B; Aukema KG; Wackett LP
Appl Environ Microbiol; 2021 May; 87(11):. PubMed ID: 33741630
[TBL] [Abstract][Full Text] [Related]
9. Biodegradation of metformin and guanylurea by aerobic cultures enriched from sludge.
Briones RM; Zhuang WQ; Sarmah AK
Environ Pollut; 2018 Dec; 243(Pt A):255-262. PubMed ID: 30179806
[TBL] [Abstract][Full Text] [Related]
10. Primary degradation of antidiabetic drugs.
Markiewicz M; Jungnickel C; Stolte S; Białk-Bielińska A; Kumirska J; Mrozik W
J Hazard Mater; 2017 Feb; 324(Pt B):428-435. PubMed ID: 27829515
[TBL] [Abstract][Full Text] [Related]
11. Biodegradation of metformin and its transformation product, guanylurea, by natural and exposed microbial communities.
Poursat BAJ; van Spanning RJM; Braster M; Helmus R; de Voogt P; Parsons JR
Ecotoxicol Environ Saf; 2019 Oct; 182():109414. PubMed ID: 31301597
[TBL] [Abstract][Full Text] [Related]
12. Uptake, translocation and possible biodegradation of the antidiabetic agent metformin by hydroponically grown Typha latifolia.
Cui H; Schröder P
J Hazard Mater; 2016 May; 308():355-61. PubMed ID: 26852211
[TBL] [Abstract][Full Text] [Related]
13. Detailed sorption characteristics of the anti-diabetic drug metformin and its transformation product guanylurea in agricultural soils.
Briones RM; Sarmah AK
Sci Total Environ; 2018 Jul; 630():1258-1268. PubMed ID: 29554747
[TBL] [Abstract][Full Text] [Related]
14. Occurrence and fate of the antidiabetic drug metformin and its metabolite guanylurea in the environment and during drinking water treatment.
Scheurer M; Michel A; Brauch HJ; Ruck W; Sacher F
Water Res; 2012 Oct; 46(15):4790-802. PubMed ID: 22770965
[TBL] [Abstract][Full Text] [Related]
15. Co-occurrence, toxicity, and biotransformation pathways of metformin and its intermediate product guanylurea: Current state and future prospects for enhanced biodegradation strategy.
Dong L; Li S; Huang J; Li WJ; Ali M
Sci Total Environ; 2024 Apr; 921():171108. PubMed ID: 38395159
[TBL] [Abstract][Full Text] [Related]
16. The elevated toxicity of the biodegradation product (guanylurea) from metformin and the antagonistic pattern recognition of combined toxicity: Insight from the pharmaceutical risk assessment and the simulated wastewater treatment.
Gao F; Wen H; Feng S; Li M; Zhu L; Zhang Y; Xi Y; Xiang X
Sci Total Environ; 2023 Sep; 892():164747. PubMed ID: 37295518
[TBL] [Abstract][Full Text] [Related]
17. Experiences with the OECD 308 transformation test: a human pharmaceutical perspective.
Ericson JF; Smith RM; Roberts G; Hannah B; Hoeger B; Ryan J
Integr Environ Assess Manag; 2014 Jan; 10(1):114-24. PubMed ID: 23794155
[TBL] [Abstract][Full Text] [Related]
18. Bioconcentration, bioaccumulation, and metabolism of pesticides in aquatic organisms.
Katagi T
Rev Environ Contam Toxicol; 2010; 204():1-132. PubMed ID: 19957234
[TBL] [Abstract][Full Text] [Related]
19. Modelling degradation kinetics of metformin and guanylurea in soil microcosms to derive degradation end-points.
Briones RM; Sarmah AK
Environ Pollut; 2019 Feb; 245():735-745. PubMed ID: 30500753
[TBL] [Abstract][Full Text] [Related]
20. Effects of guanylurea, the transformation product of the antidiabetic drug metformin, on the health of brown trout (
Jacob S; Knoll S; Huhn C; Köhler HR; Tisler S; Zwiener C; Triebskorn R
PeerJ; 2019; 7():e7289. PubMed ID: 31338260
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
